Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, it is entirely normal to feel hungry on Mounjaro, particularly in the early weeks. Tirzepatide works by activating two gut-hormone receptors that regulate appetite and slow gastric emptying, but this effect builds gradually with each dose increase. Some hunger is expected, especially at the 2.5mg starting dose. That said, most people notice a meaningful shift in appetite within the first few weeks, and persistent or worsening hunger at a maintenance dose is worth discussing with your prescriber. These medicines are prescription-only and require ongoing clinical oversight to get the most from them safely.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro (tirzepatide) activates both the GIP and GLP-1 receptors involved in appetite regulation. The result, for most people, is reduced hunger and a quicker sense of fullness after eating. But neither receptor switches on overnight. The dose you start at, 2.5mg, exists primarily to settle your digestive system rather than to suppress appetite strongly. Think of the first four weeks as an adjustment phase, not the phase where hunger disappears.
As your prescriber titrates the dose upward in roughly four-week steps, many people report that the appetite-suppressing effect becomes more pronounced. The SURMOUNT-1 trial, published in the New England Journal of Medicine, found average body-weight reductions of around 20% at the 15mg maintenance dose over 72 weeks, which implies sustained appetite change, not suppression from day one. So if you are still feeling hungry in week two, you are not doing something wrong.
It is also worth knowing that hunger is not a single sensation. Mounjaro tends to blunt physical hunger more noticeably than emotional or habitual hunger. You might still reach for something at 3pm out of routine, even when your stomach is not actually empty. Recognising that distinction helps you work with the medicine rather than concluding it is not working.
Tirzepatide is injected once a week, and blood levels peak in the day or two after the injection, then gradually taper. Some people notice that by day six or seven, appetite begins to creep back. That is a normal pharmacological pattern, not a sign of failure, and it is one of the most common things people ask our prescribers about. If you find that weekly variation significant, it is worth raising at your next clinical review rather than assuming the medicine is not right for you.
Tracking your hunger across the week, even loosely, can be genuinely useful. Many patients find a simple note on their phone, or a quick scan through the frequently asked questions before their check-in, helps them articulate what they are experiencing. Precision matters when your prescriber is deciding whether a dose increase is appropriate.
Still feeling hungry consistently across every day of the week, at a dose that should be producing more effect? That is worth reporting. The NHS tirzepatide guidance is clear that treatment should be reviewed if the medicine is not producing the expected response, and that review is a clinical conversation, not a guess.
Hunger on Mounjaro is not just about the drug. What you eat, and when, shapes how much appetite suppression you actually experience in practice. Protein is probably the most important variable: it takes longer to digest, keeps you fuller for longer, and helps preserve muscle tissue during weight loss. Meals that lean heavily on refined carbohydrates can spike and then crash blood sugar, bringing hunger back faster than a protein-and-fibre based plate would.
Hydration is another factor patients underestimate. Thirst and mild hunger can feel identical, and many people on Mounjaro who describe persistent hunger between meals are simply not drinking enough across the day. There is practical guidance on building meals that work well alongside this treatment over at what to eat on Mounjaro, which covers protein targets, fibre choices and the foods that tend to sit well on a slower gastric-emptying schedule.
One thing to hold onto: the medicine creates the conditions for eating less and feeling more satisfied, but those conditions still require some attention to what fills your plate. If you are wondering whether you can eat normal food on Mounjaro, the short answer is yes, though most people find that a slightly more protein-forward approach is when the medicine really earns its place. For a cost and treatment overview, the weight-loss treatment page sets out what private care through a GPhC-registered pharmacy typically involves.
Occasional hunger, especially in weeks one to four or immediately after a dose increase, is expected. Hunger that is genuinely worsening over time, or that comes alongside other symptoms such as nausea, vomiting or stomach pain that does not settle, deserves clinical attention rather than self-management. Mounjaro's most commonly reported side effects are gastrointestinal, and some of those, particularly nausea, can paradoxically present alongside food cravings when your body has not fully adjusted.
There are also individual health factors, such as blood-sugar variability in people with prediabetes or type 2 diabetes, that can affect hunger levels in ways that are not purely about the medicine's appetite effect. Your prescriber sees the full picture. If you are also curious about what happens to hunger across different doses, the page on hunger and Mounjaro more broadly goes into the dose-by-dose pattern in more depth.
If you are concerned about muscle loss alongside any reduction in appetite, the page on whether Mounjaro affects muscle covers what the evidence actually says and what you can do to support lean tissue. For detailed clinical reasoning behind why appetite changes work the way they do, why hunger happens on Mounjaro goes through the mechanism step by step.
Our clinical team reviews every patient's progress before any repeat or dose change, so if something feels off, that is the right moment to raise it. Our lead prescriber and the wider clinical team are available for aftercare seven days a week. If you would like to start, or to review how your current treatment is going, speaking to our prescribers is the straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.